![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0264.png)
MONDAY
TUESDAY
WEDNESDAY
THURSDAY
POSTER SESSIONS
260
009
Prolonged grief disorder behind late-life
depression evaluated based on the aspects of social
background in Japan
Kanako Shimizu, Japan
Satoshi Kato, Shiro Suda, Toshiyuki Kobayashi
010
Epilepsy and depression – questions are available
more than answers in this area
Karim Tawfik, Egypt
011
Neuropsychiatric involvement in systemic
lupus erythematosus: in a reported case of mania
Karelia Caballero, Panama
P-16
Poster Session
13:30– 15:00
|
Hall Budapest
TOPIC 4:
Affective disorders
Affective disorders: pharmacotherapy
Chair:
Göran Hajak, Germany
001
Tranylcypromine in depression: meta-analysis
of randomized controlled trials
Roland Ricken, Germany
Sven Ulrich, Angela Merkl, Peter Schlattmann,
Mazda Adli
002
Reanalysis confirms efficacy of a hypericum
extract (STW3-VI)
Jürgen Müller, Germany
Christiane Kolb
003
Efficacy of psychotherapy and pharmacotherapy
alone and in combination in treating depressive
disorders – a review
Raquel Serrano, Portugal
Rute Cajão, Teresa Carvalhão
004
Effects of cortisol on the memory bias for
emotional words? A study in patients with depres-
sion and healthy participants using the ‘directed
forgetting task’
Linn Kühl, Germany
Oliver Wolf, Martin Driessen, Nicole Schlosser,
Silvia Carvalho Fernando, Katja Wingenfeld
005
Dissecting the molecular pathways underlying
antidepressant response reveals involvement of
neurogenesis and neuronal stem cell-related genes
David Herzog, Germany
Hyobin Jeong, Diego Pascual Cuadrado, Michael A. van
der Kooij, Amitava Basu, Tanja Jene, Verena Opitz, Inge
Sillaber, Vijay K Tiwari, Marianne B. Müller
006
The feasibility of personalized antidepressant
treatment of bipolar depression
Miroslaw Latka, Poland
Wojciech Jernajczyk, Klaudia Kozowska, Anna Z.
Antosik-Wójciska, Bogdan Stefanowski, Pawel Gosek,
Lukasz Swiecicki, Bruce J. West
007
The residual symptoms and functioning of
major depressive patients partial respond with or
without remission after acute antidepressant treat-
ment in clinical setting
Le Xiao, People's Republic of China
Lei Feng, Xuequan Zhu
008
The use of newer antipsychotics in bipolar
inpatients over a seventeen year observation period
Julia Dehning, Austria
Heinz Grunze, Michaela Walpoth-Niederwanger,
Georg Kemmler, Armand Hausmann
009
Adiponectin and the unfavorable metabolic
profile in bipolar disorder
Martina Platzer, Austria
Susanne Bengesser, Armin Birner, Nina Dalkner,
Frederike Fellendorf, Carlo Hamm, Riccarda Hartleb,
René Pilz, Robert Queissner, Harald Mangge, Sieglinde
Zelzer, Hans-Peter Kapfhammer, Eva Reininghaus
010
Lithium discontinuation comes at a cost due
to increased need for inpatient care
Louise Öhlund, Sweden
Michael Ott, Sofia Oja, Malin Bergqvist, Robert
Lundqvist, Mikael Sandlund, Ellinor Salander Renberg,
Ursula Werneke
011
Behavioral effects of different doses of chole-
calciferol in the adult female rats with experimental
model of menopause
Julia Fedotova, Russia
Svetlana Pivina, Anastasia Sushko
P-17
Poster Session
13:30– 15:00
|
Hall Budapest
TOPIC 4:
Affective disorders
Affective disorders: psychotherapy and other
interventions
Chair:
Eva-Lotta Brakemeier, Germany
001
Short-term effects of a mindfulness-based at-
tention training on daily-life rumination, affect und
cortisol activity in remitted depressed individuals
Christina Timm, Germany
Bettina Ubl, Vera Zamoscik, Ulrich Ebner-Priemer,
Iris Reinhard, Peter Kirsch, Christine Kuehner
002
Efficacy of a mindful depression treatment
in a psychiatric day clinic setting: a randomized-
controlled study
Alice Buxton, Germany
Johanna Köhling, Hans-Peter Unger, Nicole Plinz,
Johannes Michalak
003
Study on the efficacy and safety of measure-
ment-based care for major depressive disorder
Xu Chen, People's Republic of China
Jingjing Zhou